Cliff Asness's CAI Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 28,994 shares of Caris Life Sciences, Inc. (CAI) worth $518,414, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in CAI, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Caris Life Sciences (CAI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Caris Life Sciences (CAI) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +28,994 | New Buy | 28,994 | $17.88 |
Cliff Asness's Caris Life Sciences Investment FAQs
Cliff Asness first purchased Caris Life Sciences, Inc. (CAI) in Q1 2026, acquiring 28,994 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Caris Life Sciences, Inc. (CAI) for 1 quarters since Q1 2026.
Cliff Asness's largest addition to Caris Life Sciences, Inc. (CAI) was in Q1 2026, adding 28,994 shares worth $518,414.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 28,994 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $518,414.
As of the Q1 2026 filing, Caris Life Sciences, Inc. (CAI) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Caris Life Sciences, Inc. (CAI) was 28,994 shares, as reported at the end of Q1 2026.